Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Country |
Year |
Project |
Sample size |
First use age 13 or before |
Perceived availability |
Use 40+ times |
Use 40+ times males |
Use 40+ times females |
|---|---|---|---|---|---|---|---|---|
Belgium |
2003 |
ESPAD |
2320 |
7 |
49 |
7 |
11 |
4 |
Czech Republic |
2003 |
ESPAD |
3195 |
6 |
58 |
9 |
12 |
6 |
Denmark |
2003 |
ESPAD |
2978 |
6 |
52 |
2 |
3 |
2 |
Germany (a) |
2003 |
ESPAD |
5110 |
9 |
41 |
5 |
6 |
3 |
Estonia |
2003 |
ESPAD |
2463 |
4 |
23 |
3 |
5 |
0 |
Greece |
2003 |
ESPAD |
1906 |
1 |
20 |
1 |
1 |
1 |
France |
2003 |
ESPAD |
2199 |
|
47 |
9 |
14 |
5 |
Ireland |
2003 |
ESPAD |
2407 |
8 |
60 |
7 |
6 |
7 |
Italy |
2003 |
ESPAD |
4871 |
4 |
44 |
6 |
8 |
4 |
Cyprus |
2003 |
ESPAD |
2152 |
1 |
12 |
1 |
1 |
0 |
Latvia |
2003 |
ESPAD |
2841 |
3 |
22 |
1 |
2 |
0 |
Lithuania |
2003 |
ESPAD |
5036 |
1 |
20 |
1 |
2 |
0 |
Hungary |
2003 |
HBSC(WHO) |
1330 |
|
|
1 |
2 |
0 |
Hungary |
2003 |
ESPAD |
2677 |
2 |
20 |
1 |
2 |
1 |
Malta |
2003 |
ESPAD |
3500 |
2 |
20 |
1 |
2 |
1 |
Netherlands |
2003 |
ESPAD |
2095 |
8 |
42 |
6 |
9 |
3 |
Austria |
2003 |
ESPAD |
2402 |
5 |
33 |
4 |
4 |
2 |
Poland |
2003 |
ESPAD |
5964 |
1 |
37 |
2 |
4 |
1 |
Portugal |
2003 |
ESPAD |
2946 |
4 |
29 |
3 |
5 |
2 |
Slovenia |
2003 |
ESPAD |
2785 |
7 |
55 |
6 |
7 |
5 |
Slovakia |
2003 |
ESPAD |
2276 |
5 |
49 |
3 |
5 |
2 |
Finland |
2003 |
ESPAD |
3543 |
2 |
19 |
0 |
1 |
0 |
Sweden |
2003 |
ESPAD |
3232 |
1 |
23 |
0 |
1 |
0 |
United Kingdom |
2003 |
ESPAD |
2068 |
13 |
58 |
10 |
13 |
6 |
Norway |
2003 |
ESPAD |
3833 |
3 |
26 |
1 |
2 |
1 |
Bulgaria |
2003 |
ESPAD |
2740 |
3 |
36 |
3 |
4 |
2 |
Romania |
2003 |
ESPAD |
4371 |
0 |
10 |
0 |
0 |
0 |
Turkey (a) |
2003 |
ESPAD |
4177 |
1 |
7 |
1 |
1 |
0 |
Notes: Perceived availability: Perceived availability of cannabis is the percentage of students answering 'very easy' or 'fairly easy' (in the 6-point scale) to the question 'How difficult do you think it would be for you to get cannabis, if you wanted?' Use 40+ times: in ESPAD surveys during lifetime. Comparison between males and females for use 40+ times is limited, because numbers are often too small to be statistically significant. (a) ESPAD 2003 Germany figures are based in six regions only (Bavaria, Brandenburg, Berlin, Hesse, Mecklenburg-Western Pomerania and Thuringia). Turkey figures are based on one major city in each of six different regions (Adana, Ankara, Diyarbakir, Istanbul, Izmir and Samsun). See also 'General notes for interpreting data' on the Explanatory notes and help page. Sources: See Table EYE-0. | ||||||||